The emergence of TP-53-targeted cancer therapeutics signifies a watershed moment in oncological precision medicine, generating substantial commercial opportunities through addressing critical therapeutic gaps across diverse malignancy types. This advanced market analysis examines an industry vertical positioned for accelerated growth, underpinned by solid scientific evidence, progressive...